Market Herald logo

Subscribe

Be the first with the news that moves the market
  • BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform
  • BioVaxys filed an  international patent application through the Patent Cooperation Treaty (“PCT”) for BVX-1021, its vaccine for SARS1 and other sarbecoviruses
  • CEO James Passin sat down with Sabrina Cuthbert to discuss the news
  • BioVaxys Technology is a clinical-stage biotechnology company that is developing viral and oncology vaccine platforms
  • BioVaxys Technology Corp. (BIOV) opened trading at C$0.11 per share.

BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform.

BioVaxys filed an international patent application through the Patent Cooperation Treaty (“PCT”) for BVX-1021, it’s vaccine for SARS1 and other sarbecoviruses.

BVX-1021 is the subject of an ongoing research collaboration between The Ohio State University and BioVaxys that is evaluating the Company’s novel approach for a ‘universal vaccine’ that can treat a broad range of sarbecoviruses. 

An International PCT Application, which is a patent treaty with more than 150 member countries, makes it possible to seek patent protection for an invention simultaneously in a large number of countries by filing a single ‘international’ patent application.

CEO James Passin sat down with Sabrina Cuthbert to discuss the news.

BioVaxys Technology is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumour types.

BioVaxys Technology Corp. (BIOV) opened trading at C$0.11 per share.


More From The Market Herald
The Market Herald Video

" Datametrex AI (TSXV:DM) subsidiary Nexalogy announces pending launch of AnalyticsGPT

Datametrex AI (DM) subsidiary, Nexalogy Environics, is working towards launching AnalyticsGPT.
The Market Herald Video

" Platinex (CSE:PTX) acquires Ontario gold assets, signs agreement with Fancamp (TSXV:FNC)

Platinex (PTX) has signed an agreement with Fancamp Exploration (FNC).

" @ the Bell: TSX sees flat finish in the red on mining losses

Base metals losses helped lead Canada’s main stock index lower in Wednesday trading.

" Titan Medical (TSX:TMD) undertakes review and evaluation

Titan Medical (TMD) gets real about its future in the health sector Raymond James was hired to undertake a review of